We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
ESS Tech
GWH
$18.9M
| $1.03M | ﹤0.01% |
16,856
-59
| -0.3% | -$3.49K |
|
|
ZIMV
2702
DELISTED
ZimVie
ZIMV
| $1.03M | ﹤0.01% |
104,699
-38,246
| -27% | -$617K |
|
|
EGIO
2703
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.03M | ﹤0.01% |
9,274
-195
| -2% | -$23.1K |
|
|
ONTF
2704
DELISTED
ON24
ONTF
| $1.03M | ﹤0.01% |
117,034
-1,565
| -1% | -$15K |
|
2705
Motorcar Parts of America
MPAA
$258M
| $1.03M | ﹤0.01% |
67,536
-324
| -0.5% | -$4.75K |
|
|
DSEY
2706
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $1.03M | ﹤0.01% |
211,582
-3,005
| -1% | -$19.1K |
|
|
IGMS
2707
DELISTED
IGM Biosciences
IGMS
| $1.03M | ﹤0.01% |
45,184
-42,505
| -48% | -$858K |
|
|
VTNR
2708
DELISTED
Vertex Energy, Inc
VTNR
| $1.02M | ﹤0.01% |
164,532
-221,293
| -57% | -$2.03M |
|
2709
Frontier Group Holdings
ULCC
$1.7B
| $1.02M | ﹤0.01% |
105,098
-179,313
| -63% | -$2.2M |
|
2710
Outlook Therapeutics
OTLK
$191M
| $1.02M | ﹤0.01% |
41,763
+417
| +1% | +$9.7K |
|
2711
John Marshall Bancorp
JMSB
$329M
| $1.01M | ﹤0.01% |
41,330
-685
| -2% | -$17.4K |
|
|
EBTC
2712
DELISTED
Enterprise Bancorp
EBTC
| $1.01M | ﹤0.01% |
33,882
-298
| -0.9% | -$9.58K |
|
2713
Daily Journal
DJCO
$778M
| $1.01M | ﹤0.01% |
3,940
-80
| -2% | -$21.1K |
|
2714
Transocean
RIG
$5.82B
| $1.01M | ﹤0.01% |
407,557
-24,015
| -6% | -$76.8K |
|
2715
Quantum-Si Incorporated
QSI
$177M
| $1M | ﹤0.01% |
365,401
+5,045
| +1% | +$16.1K |
|
2716
Bridgford Foods
BRID
$56.5M
| $1M | ﹤0.01% |
70,834
| – | – |
|
2717
Aviat Networks
AVNW
$273M
| $1M | ﹤0.01% |
36,520
-152
| -0.4% | -$4.56K |
|
2718
Vita Coco
COCO
$3.6B
| $999K | ﹤0.01% |
87,734
+531
| +0.6% | +$6.92K |
|
2719
First Business Financial Services
FBIZ
$595M
| $998K | ﹤0.01% |
30,912
+4
| +0% | +$133 |
|
2720
MVB Financial
MVBF
$389M
| $997K | ﹤0.01% |
35,819
-651
| -2% | -$20.9K |
|
2721
Immunovant
IMVT
$8.25B
| $995K | ﹤0.01% |
178,428
-3,089
| -2% | -$15.1K |
|
|
MAGN
2722
Magnera Corp
MAGN
$460M
| $994K | ﹤0.01% |
24,587
-765
| -3% | -$53.2K |
|
2723
Southern First Bancshares
SFST
$600M
| $992K | ﹤0.01% |
23,795
-429
| -2% | -$19K |
|
2724
AXT Inc
AXTI
$5.8B
| $989K | ﹤0.01% |
147,602
-11,194
| -7% | -$88K |
|
2725
Janux Therapeutics
JANX
$967M
| $987K | ﹤0.01% |
72,877
-1,996
| -3% | -$26.7K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.